Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of $10.71 billion. The enterprise value is $9.74 billion.

Market Cap	10.71B
Enterprise Value	9.74B

Important Dates

The next confirmed earnings date is Friday, August 9, 2024, before market open.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Legend Biotech has 182.28 million shares outstanding.

Shares Outstanding	182.28M
Owned by Insiders (%)	1.32%
Owned by Institutions (%)	49.06%
Float	159.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.24
Forward PS	16.84
PB Ratio	9.20
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	28.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.66, with a Debt / Equity ratio of 0.29.

Current Ratio	5.66
Quick Ratio	5.23
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.12

Financial Efficiency

Return on equity (ROE) is -36.10% and return on invested capital (ROIC) is -21.47%.

Return on Equity (ROE)	-36.10%
Return on Assets (ROA)	-25.20%
Return on Capital (ROIC)	-21.47%
Revenue Per Employee	$187,732
Profits Per Employee	-$255,173
Employee Count	1,826
Asset Turnover	0.19
Inventory Turnover	9.52

Taxes

Income Tax	-1.99M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.59% in the last 52 weeks. The beta is 0.11, so Legend Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-16.59%
50-Day Moving Average	45.44
200-Day Moving Average	56.11
Relative Strength Index (RSI)	76.92
Average Volume (20 Days)	1,258,559

Short Selling Information

Short Interest	11.16M
Short Previous Month	11.00M
Short % of Shares Out	11.77%
Short % of Float	n/a
Short Ratio (days to cover)	8.58

Income Statement

In the last 12 months, Legend Biotech had revenue of $342.80 million and -$465.95 million in losses. Loss per share was -$2.58.

Revenue	342.80M
Gross Profit	179.46M
Operating Income	-321.74M
Pretax Income	-467.93M
Net Income	-465.95M
EBITDA	n/a
EBIT	-445.78M
Loss Per Share	-$2.58

Full Income Statement

Balance Sheet

The company has $1.30 billion in cash and $334.69 million in debt, giving a net cash position of $968.05 million or $5.31 per share.

Cash & Cash Equivalents	1.30B
Total Debt	334.69M
Net Cash	968.05M
Net Cash Per Share	$5.31
Equity (Book Value)	1.16B
Book Value Per Share	6.39
Working Capital	1.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$296.03 million and capital expenditures -$27.17 million, giving a free cash flow of -$323.20 million.

Operating Cash Flow	-296.03M
Capital Expenditures	-27.17M
Free Cash Flow	-323.20M
FCF Per Share	-$1.78

Full Cash Flow Statement

Margins

Gross margin is 52.35%, with operating and profit margins of -93.86% and -135.92%.

Gross Margin	52.35%
Operating Margin	-93.86%
Pretax Margin	-136.50%
Profit Margin	-135.92%
EBITDA Margin	n/a
EBIT Margin	-130.04%
FCF Margin	-94.28%

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.08%
Shareholder Yield	-10.08%
Earnings Yield	-4.35%
FCF Yield	-3.02%

Dividend Details

Analyst Forecast

The average price target for Legend Biotech is $80.54, which is 37.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$80.54
Price Target Difference	37.11%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	59.00%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4